Zanidatamab with and without Tislelizumab in HER2-Positive Gastroesophageal Cancer - Kohei Shitara; Elena Elimova; Tianshu Liu; Josep Tabernero; Keun-Wook Lee; Michael Schenker; Niall C. Tebbutt; Jaffer Ajani; Norhidayu Salimin; Geoffrey Ku; Jong Gwang Kim; Inmaculada Ales Diaz; et al. (New England Journal of Medicine, 2026)